• CSL Behring Presents rIX-FP for Hemophilia B Phase III Data Evaluating Efficacy, Safety and Improved Dosing at ISTH 2015

    – Data supports prolonged dosing intervals up to 14 days for routine prophylaxis in hemophilia B patients

    – Majority of adult and pediatric patients using rIX-FP for routine prophylaxis had an annualized spontaneous bleeding rate (AsBR) of 0.00
    – Surgical sub study results show single dose of rIX-FP sufficient to maintain hemostasis during surgery
    TORONTO, June 24, 2015 /PRNewswire/ — …

    READ MORE
  • CSL Behring Announces Pivotal Data of Novel rVIII-SingleChain Therapy in Adolescents and Adults with Hemophilia A

    Data presented during Late Breaking Session at the 2015 ISTH Congress showed:

    Patients using rVIII-SingleChain prophylactically to prevent bleeding were well controlled when dosed only two or three times weekly
    Prophylactic dosing resulted in low annualized spontaneous bleeding rates and the majority of treated bleeds were controlled with only one dose
    rVIII-SingleChain had improved pharmacokinetic parameters compared with …

    READ MORE
  • Bayer Hemophilia Awards Program Recognizes Researchers for Nanomedicines, Gene Therapies and Bioengineering Factor VIII

    As part of its commitment to support early-stage research in hemophilia and related bleeding disorders, Bayer HealthCare has awarded Bayer Hemophilia Awards Program (BHAP) grants to clinicians and researchers from six hospitals and research institutions in the United States. BHAP grants will support research into numerous projects, including nanomedicines, new methods to improve inhibitor detection …

    READ MORE
  • Update in the Reversal of Oral Anticoagulants: New Developments and Clinical Strategies

    In the past decade, new oral anticoagulants (NOACs) have transformed the prophylaxis and treatment of thromboembolism. However, few data are available on the reversal of NOACs. Clinicians may face challenges when patients using NOACs present with bleeding complications or prior to urgent interventional procedures.
    Please join us for the symposium Update in the Reversal of Oral …

    READ MORE
  • First insights from the RE-VERSE AD patient study – Idarucizumab* reversed the anticoagulant effect of dabigatran within minutes

    The results from an interim analysis of the phase III RE-VERSE AD patient study presented by lead investigator Charles Pollack, professor of emergency medicine at the Perelman School of Medicine of the University of Pennsylvania School of Medicine, Philadelphia, demonstrated that 5 grams of idarucizumab* immediately reversed the anticoagulant effect of dabigatran etexilate in patients …

    READ MORE
  • The Hemochron Signature Elite Whole Blood Microcoagulation System

    RapidCount – Because Every Second Counts
    The Hemochron Signature Elite is a comprehensive point-of-care coagulation monitoring system and is ideal for the wide variety of applications found in today’s busy health care facilities.
    Rapid Time to Get Patients on Pump
    With our proprietary RapidCount technology integrated into the ACT+ test, a 450-second target time may be achieved in …

    READ MORE
  • Avoximeter 1000E Whole Blood Oximeter and 4000 Whole Blood CO-Oximeter

    Avoximeter 1000E Whole Blood Oximeter
    The Avoximeter 1000E Whole Blood Oximeter provides rapid, accurate oximetry assessment for the cardiac catheterization lab. Today’s clinicians seek technology that helps to provide a more accurate diagnosis during cardiac catheterization procedures. The portable Avoximeter 1000E measures total hemoglobin concentration, oxyhemoglobin fraction and computes oxygen concentration in less than 10 seconds.

    Assists …

    READ MORE
  • The VerifyNow System

    The VerifyNow System provides an easy, rapid and proven solution to assess your patient’s platelet reactivity to antiplatelet medications such as aspirin, clopidogrel, and GP IIb/IIIa inhibitors.
    Antiplatelet medications are given with the assumption that all patients respond equally, but they do not. VerifyNow is the first rapid, accurate system for measuring individual response to P2Y12 inhibitors. …

    READ MORE
  • The Hemochron Signature Elite Whole Blood Microcoagulation System

    RapidCount – Because Every Second Counts
    The Hemochron Signature Elite is a comprehensive point-of-care coagulation monitoring system and is ideal for the wide variety of applications found in today’s busy health care facilities.
    Rapid Time to Get Patients on Pump
    With our proprietary RapidCount technology integrated into the ACT+ test, a 450-second target time may be achieved …

    READ MORE
  • Incision devices

    Discover which is best for your patient’s needs with our patented SoftSweep technology.
    Tenderfoot is a safe, gentle and effective device for obtaining blood samples from the heels of infants.

    The result is a high quality blood sample with significantly less pain, bruising, and need for re-sticks.
    Tenderfoot produces a consistent incision that is controlled to a depth just above …

    READ MORE
  • Move against thrombosis during ISTH 2015 Congress by taking the Time2Move Ultrasound and Step Challenge!

    Did you take a long-haul flight to Toronto? Are you at risk of a DVT? Head to Booth #1722 to take the two-step Time2Move Challenge — first get your leg scanned and test your peak popliteal vein flow velocity and then join the Step Challenge for a little “healthy” competition. Make all that walking between …

    READ MORE
  • ITAC-CME launches VTE & cancer mobile app

    Provides rapid access to international VTE & cancer treatment guidelines to quickly determine a recommended course of action for any given patient
    The International Initiative on Thrombosis and Cancer (ITAC-CME) is a multidisciplinary group of leading clinicians and researchers from across the globe that developed and published “2013 International Clinical Practice Guidelines for the Treatment and …

    READ MORE
  • GARFIELD-AF Registry data to provide real-world insights into stroke prevention in patients with atrial fibrillation

    New data from nearly 17,200 patients enrolled in the Global Anticoagulant Registry in the Field – Atrial Fibrillation (GARFIELD-AF) will be presented at the International Society on Thrombosis and Haemostasis (ISTH) 2015 Congress. The two oral presentations will include real-life data on stroke prevention, providing physicians with further information on how higher risk scores (CHA2DS2-VASc …

    READ MORE
  • New clinical data on the benefit-risk profile of Bayer’s rivaroxaban and real life insights to be presented at ISTH 2015

    Bayer HealthCare has announced that new clinical data on its oral Factor Xa inhibitor rivaroxaban along with further real life insights will be presented at the  International Society on Thrombosis and Haemostasis (ISTH) 2015 Congress, providing physicians with a broader understanding of blood clot management in everyday clinical practice.
    Notable presentations include:

    Six oral presentations from the EINSTEIN Clinical …

    READ MORE
  • ISTH and industry partners recognize the integral role of nurses through interactive informational sessions

    Nurses play an integral role in caring for those affected by inherited bleeding disorders and improving access to treatment. This year’s ISTH Congress recognizes these contributions during a two-day forum designed to support continued education for professional nurses from across the globe.
    The Nurses’ Forum and Allied Health Professionals’ Scientific Session will be stationed throughout the …

    READ MORE
  • Sponsors and partners

    The ISTH 2015 Congress would not be possible without the generous support of our sponsors and partners. View our ISTH 2015 sponsors and partners below.
    Platinum level sponsors
    Baxalta
    Bayer HealthCare
    Biogen and Sobi
    Novo Nordisk Health Care AG
    Octapharma AG
     
    Gold level sponsors
    Boehringer Ingelheim GmbH
    CSL Behring GmbH
    Pfizer
    Pfizer Canada Inc./Bristol-Myers Squib Canada
     
    Silver level sponsors
    Daiichi-Sankyo, Inc.
    Kedrion Biopharma
    Siemens Healthcare and Sysmex Corporation
    STAGO
     
    Bronze level sponsors
    Alexion Pharmaceuticals, Inc.
    GRIFOLS
    HYPHEN BioMed
    Instrumentation …

    READ MORE